Bank of Montreal Can grew its position in shares of Agilent Technologies Inc (NYSE:A) by 187.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 742,001 shares of the medical research company’s stock after purchasing an additional 483,721 shares during the quarter. Bank of Montreal Can’s holdings in Agilent Technologies were worth $49,693,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Dupont Capital Management Corp bought a new position in shares of Agilent Technologies during the 3rd quarter valued at about $101,000. Balentine LLC increased its position in shares of Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after purchasing an additional 50 shares during the last quarter. Sun Life Financial INC increased its position in shares of Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after purchasing an additional 2,353 shares during the last quarter. Steward Partners Investment Advisory LLC bought a new position in shares of Agilent Technologies during the 3rd quarter valued at about $213,000. Finally, Cannell Peter B & Co. Inc. bought a new position in shares of Agilent Technologies during the 3rd quarter valued at about $215,000.

A has been the topic of several recent research reports. Robert W. Baird reiterated a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research report on Tuesday, October 10th. Deutsche Bank set a $75.00 price target on Agilent Technologies and gave the stock a “buy” rating in a research report on Tuesday, November 21st. Barclays restated a “buy” rating and set a $74.00 price target on shares of Agilent Technologies in a research report on Monday, January 8th. Finally, Cowen restated a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $69.25.

In other news, CEO Michael R. Mcmullen sold 43,703 shares of Agilent Technologies stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $70.00, for a total value of $3,059,210.00. Following the sale, the chief executive officer now directly owns 302,837 shares in the company, valued at approximately $21,198,590. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Mark Doak sold 4,154 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $67.00, for a total value of $278,318.00. Following the completion of the sale, the vice president now owns 68,270 shares in the company, valued at $4,574,090. The disclosure for this sale can be found here. Over the last quarter, insiders sold 198,141 shares of company stock worth $13,830,045.

Agilent Technologies Inc (A) opened at $73.07 on Friday. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. Agilent Technologies Inc has a 1 year low of $47.05 and a 1 year high of $73.21. The stock has a market capitalization of $23,318.67, a P/E ratio of 34.80, a P/E/G ratio of 2.18 and a beta of 1.28.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the company earned $0.59 EPS. Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. analysts predict that Agilent Technologies Inc will post 2.58 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a $0.149 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is currently 28.57%.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/21/agilent-technologies-inc-a-holdings-increased-by-bank-of-montreal-can.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.